TLR4 and metabolic dysfunction-associated steatohepatitis: Although the suppression of the LPS/TLR-4 signaling pathway may be related to the anti-inflammatory effects of SHED-CM on macrophages, at least, part of the therapeutic benefits of SHED-CM on NASH mice may be mediated by protection of the intestinal barrier.